BeStock  
股票 › 生物科技 › RYTM

节律制药 RYTM

美股市值排名 #1672生物科技
$112.28 +$7.26 (+6.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $112.80 +0.46%
开盘$107.10
昨收$105.02
当日区间$104.31 – $113.29
成交量4.94M
市值$7.78B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$71.26M+46.9% YoY
营业利润-$48.55M-7.2% YoY
净利润-$49.30M-5.7% YoY
摊薄每股收益-$0.73+2.7% YoY
自由现金流-$9.15M+60.7% YoY
经营现金流-$9.15M

营收,近8个季度

$33.3MSep '24$41.8MDec '24$32.7MMar '25$48.5MJun '25$51.3MSep '25$57.3MDec '25$60.1MMar '26$71.3MJun '26

净利润,近8个季度

$-43.6MSep '24$-43.3MDec '24$-49.5MMar '25$-46.6MJun '25$-52.9MSep '25$-47.5MDec '25$-55.6MMar '26$-49.3MJun '26

各季度摊薄每股收益

-0.73Sep '24-0.72Dec '24-0.81Mar '25-0.75Jun '25-0.82Sep '25-0.73Dec '25-0.83Mar '26-0.73Jun '26

各季度自由现金流

$14.8MSep '24$-18.8MDec '24$-40.4MMar '25$-23.3MJun '25$-26.6MSep '25$-26.3MDec '25$-44.2MMar '26$-9.2MJun '26

年度营收

$0.0FY20$3.2MFY21$23.6MFY22$77.4MFY23$130.1MFY24$189.8MFY25

盈利能力与资产负债表

毛利率89.0%
营业利润率-83.6%
净利率-87.6%
净资产收益率-461.6%
资产收益率-51.9%
投入资本回报率-420.9%
流动比率3.45
负债/资产比率50.3%
现金及投资$330.90M
总负债$2.98M
净现金(净负债)$327.92M

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $71.26M $60.11M $189.76M $57.25M $51.30M
营业总收入 $71.26M $60.11M $189.76M $57.25M $51.30M
营业成本 $8.93M $7.16M $19.49M $4.80M $5.50M
毛利润 $62.32M $52.96M $170.27M $52.45M $45.80M
营业费用 $110.88M $105.32M $362.28M $99.51M $98.45M
销售及管理费用 $67.45M $63.59M $194.94M $57.48M $52.43M
研发费用 $43.43M $41.73M $167.34M $42.03M $46.03M
营业利润 -$48.55M -$52.36M -$192.02M -$47.06M -$52.65M
非经营性利息净收入(支出) -$1.32M -$1.03M -$5.29M -$530,000.00 -$414,000.00
非经营性利息收入 $3.22M $3.55M $15.29M $4.09M $4.33M
非经营性利息支出 $4.54M $4.58M $20.58M $4.62M $4.74M
其他收入(支出) $1.02M -$1.70M $1.26M $57,000.00 $274,000.00
其他非经营性收入(支出) $1.02M -$1.70M $1.26M $57,000.00 $274,000.00
税前利润 -$48.85M -$55.09M -$196.04M -$47.54M -$52.79M
税费 $444,000.00 $545,000.00 $497,000.00 -$31,000.00 $111,000.00
净利润 -$49.30M -$55.64M -$196.54M -$47.51M -$52.90M
持续经营利润 -$49.30M -$55.64M -$196.54M -$47.51M -$52.90M
归属母公司净利润 -$49.30M -$55.64M -$196.54M -$47.51M -$52.90M
优先股股息 $1.07M $1.10M $5.38M $1.33M $1.38M
归属普通股股东净利润 -$50.36M -$56.74M -$201.92M -$48.84M -$54.28M
基本每股收益 -$0.73 -$0.83 -$3.11 -$0.73 -$0.82
摊薄每股收益 -$0.73 -$0.83 -$3.11 -$0.73 -$0.82

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $437.27M $442.32M $480.20M $480.20M $506.87M
流动资产合计 $426.56M $430.09M $466.92M $466.92M $494.80M
现金及现金等价物与短期投资 $330.90M $340.63M $388.95M $388.95M $416.05M
-现金及现金等价物 $65.61M $62.14M $54.30M $54.30M $52.08M
-短期投资 $265.28M $278.49M $334.65M $334.65M $363.97M
应收款 $40.41M $34.19M $26.08M $26.08M $33.03M
-应收账款 $40.41M $34.19M $26.08M $26.08M $33.03M
存货 $30.52M $28.65M $25.75M $25.75M $22.11M
其他流动资产 $24.74M $26.62M $9.97M $9.97M $23.61M
非流动资产合计 $10.70M $12.23M $13.28M $13.28M $12.07M
固定资产净值 $2.92M $4.00M $4.15M $4.15M $3.40M
-固定资产原值 $2.92M $4.00M $9.40M $9.40M $3.40M
商誉及其他无形资产 $4.89M $5.11M $5.32M $5.32M $5.53M
-其他无形资产 $4.89M $5.11M – – $5.53M
其他非流动资产 $2.89M $3.12M $3.81M $3.81M $3.14M
负债合计 $219.97M $204.70M $210.17M $210.17M $211.19M
流动负债合计 $123.59M $103.20M $105.94M $105.94M $104.27M
应付款 $16.17M $12.30M $13.95M $13.95M $13.63M
-应付账款 $16.17M $12.30M $13.95M $13.95M $13.63M
一年内应计费用 $86.70M $74.90M $79.78M $79.78M $81.06M
短期债务及融资租赁负债 $703,000.00 $676,000.00 $650,000.00 $650,000.00 $624,000.00
-一年内到期融资租赁负债 $703,000.00 $676,000.00 $650,000.00 $650,000.00 $624,000.00
一年内递延负债 $12.70M $10.18M $7.49M $7.49M $5.56M
其他流动负债 $7.31M $5.15M $4.08M $4.08M $3.40M
非流动负债合计 $96.38M $101.50M $104.23M $104.23M $106.92M
长期债务及融资租赁负债 $2.98M $3.16M $3.34M $3.34M $3.52M
-长期融资租赁负债 $2.98M $3.16M $3.34M $3.34M $3.52M
一年以上递延负债 $93.40M $98.34M $100.89M $100.89M $103.41M
股东权益合计 $217.30M $237.62M $270.03M $270.03M $295.68M
股东权益 $217.30M $237.62M $270.03M $270.03M $295.68M
股本 $114.39M $114.78M $131.02M $131.02M $146.93M
-普通股 $69,000.00 $69,000.00 $67,000.00 $67,000.00 $67,000.00
-优先股 $114.32M $114.71M $130.96M $130.96M $146.87M
资本公积 $1.56B $1.53B $1.49B $1.49B $1.45B
留存收益 -$1.46B -$1.41B -$1.35B -$1.35B -$1.30B
不影响留存收益的损益 -$912,000.00 $444,000.00 -$796,000.00 -$796,000.00 -$926,000.00
预付资产 – – $16.17M $16.17M –
-累计折旧 – – -$5.25M -$5.25M –
衍生产品负债 – – $0.00 $0.00 –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$9.15M -$44.19M -$115.68M -$25.39M -$26.62M
持续经营经营活动现金流净额 -$9.15M -$44.19M -$115.68M -$25.39M -$26.62M
持续经营净利润 -$49.30M -$55.64M -$196.54M -$47.51M -$52.90M
持续经营损益 -$785,000.00 $1.68M -$910,000.00 $309,000.00 $910,000.00
折旧、折耗与摊销 $251,000.00 $252,000.00 $1.34M $272,000.00 $304,000.00
其他非现金项目 $5.15M $4.87M $21.10M $4.82M $4.85M
营运资金变动 $10.65M -$17.01M -$968,000.00 -$691,000.00 $3.11M
-应收款变动 -$6.22M -$8.11M -$7.57M $6.18M -$6.60M
-存货变动 -$2.34M -$3.09M -$7.47M -$4.93M -$2.45M
-预付资产变动 $2.80M -$487,000.00 -$6.33M -$2.71M $6.39M
-应付账款及应计费用变动 $16.46M -$5.62M $21.89M $1.26M $11.02M
-其他流动资产变动 $0.00 $435,000.00 -$397,000.00 -$681,000.00 -$5.24M
-其他营运资金变动 -$49,000.00 -$145,000.00 -$1.09M $194,000.00 $0.00
投资活动现金流净额 $14.01M $57.05M -$137.15M $30.35M -$246.35M
持续经营投资活动现金流净额 $14.01M $57.05M -$137.15M $30.35M -$246.35M
投资购置及出售净额 $14.01M $57.05M -$96.20M $31.30M -$206.35M
筹资活动现金流 -$1.17M -$5.40M $217.96M -$2.95M $189.30M
持续经营筹资活动现金流净额 -$1.17M -$5.40M $217.96M -$2.95M $189.30M
普通股发行净额 $0.00 $0.00 $222.69M $2,000.00 $188.66M
股票期权行使所得 $7.00M $7.35M $15.19M $2.45M $6.22M
其他筹资费用净额 -$8.16M -$12.75M -$19.92M -$5.40M -$5.57M
期末现金余额 $66.22M $62.74M $54.82M $54.82M $52.75M
现金净变动 $3.70M $7.47M -$34.87M $2.01M -$83.67M
期初现金余额 $62.74M $54.82M $89.60M $52.75M $136.11M
汇率变动影响 -$217,000.00 $448,000.00 $87,000.00 $64,000.00 $304,000.00
自由现金流 -$9.15M -$44.19M -$116.63M -$26.34M -$26.62M
固定资产购置及出售净额 – – -$953,000.00 – –
其他投资变动净额 – – -$40.00M $0.00 –
优先股发行净额 – – $0.00 $0.00 –

讨论区

暂无评论——快来第一个聊聊 RYTM。

登录后参与讨论。

Scroll to Top